Review: Cardiac resynchronization therapy reduces morbidity and mortality in left ventricular systolic dysfunction

November 2007
ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p58
Academic Journal
The article focuses on a study, that focuses on the effects of cardiac resynchronization therapy (CRT) on patients with left ventricular systolic dysfunction (LVSD). It mentions the data sources used to conduct the study, the theory on which it is based and its outcome. It concludes that CRT led to lower incidences of all-cause mortality and hospitalization for heart failure (HF).


Related Articles

  • Treatment of heart failure with reduced left ventricular ejection fraction. Aronow, Wilbert S. // Geriatrics;Mar2006, Vol. 61 Issue 3, p22 

    Heart failure (HF) affects approximately 5 million persons in the United States each year. HF is predominantly a disease of the elderly: Approximately 80% of patients hospitalized with HF are older than age 65. Approximately one-half of older adult patients with CHF have a decreased ejection...

  • Levosimendan: A Review of its Use in the Management of Acute Decompensated Heart Failure. Innes, Carmen A.; Wagstaff, Antona L // Drugs;2003, Vol. 63 Issue 23, p2651 

    Levosimendan (Simdax[sup ®]) is a calcium-sensitising drug that stabilises the troponin molecule in cardiac muscle, thus prolonging its effects on contractile proteins, with concomitant vasodilating properties. Intravenous levosimendan (12–24 μg/kg loading dose followed by...

  • To revascularize or not to revascularize: a dilemma in heart failure. Senior, Roxy // CMAJ: Canadian Medical Association Journal;8/15/2006, Vol. 175 Issue 4, p372 

    The article comments on a study which compared the rate of death between patients with heart failure treated with revascularization and those who are treated with medical therapy. The methodology of the study is described. Clinical information on coronary revascularization is provided. The rate...

  • BiV Pacing in Class IV Heart Failure. DiMarco, John P. // Clinical Cardiology Alert;Mar2007, Vol. 26 Issue 3, p19 

    Cardiac resychronization therapy reduces morbidity and mortality in class IV heart failure patients.

  • Nesiritide for CHF May Increase Mortality Risk. Slawson, David // American Family Physician;8/1/2005, Vol. 72 Issue 3, p510 

    Discusses research being done on the efficacy of nesiritide in the treatment of patients with congestive heart failure. Reference to a study by J. D. Sackner-Bernstein and colleagues published in the April 20, 2005 issue of "Journal of American Medical Association"; Mortality rates among...

  • Beneficios clínicos de la resincronización cardiaca. Guevara-Valdivia, Milton E. // Archivos de Cardiología de México;2009 Supplement 2, Vol. 79 Issue 5, p71 

    Despite the improvement in pharmacologic treatment of heart failure, many patients continue to have severe persistent symptoms, and their prognosis remains poor. One of the most recent advances in heart failure management is the concept of cardiac resynchronization therapy (CRT). Large clinical...

  • Inotropes do not increase mortality in advanced heart failure. Guglin, Maya; Kaufman, Marc // International Journal of General Medicine;2014, Vol. 7, p237 

    Inotrope use is one of the most controversial topics in the management of heart failure. While the heart failure community utilizes them and recognizes the state of inotrope dependency, retrospective analyses and registry data have overwhelmingly suggested high mortality, which is logically to...

  • Registrar: MRCGP Exam Update - Heart failure and beta-blockers. Newson, Louise // GP: General Practitioner;1/20/2006, p60 

    The article provides information on heart failure and beta-blockers. Despite strong evidence that beta-blockers increase the length and quality of life in people with heart failure, only 37 per cent of eligible patients are receiving a beta-blocker. Recent large, randomised, controlled trials...

  • Triumph of common sense. Robeznieks, Andis // Modern Healthcare;12/5/2005, Vol. 35 Issue 49, p12 

    The article discusses a study on the clinical application of evidence-based practice to improve heart failure treatment. The study states that not all providers are using evidence-based guidelines. The study involved 2,500 heart-failure patients. The study found out that using evidence-based...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics